Pfizer had recently shown promising results in terms of vaccine protection against other COVID-19 variants, including the current variant of concern, named Omicron. According to preliminary results from a South African study, Pfizer’s vaccine shot offered about 70 percent protection against hospitalization during a recent Omicron surge in South Africa, and had substantially yielded fewer antibodies against the Omicron variant.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>